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Problem of Prematurity
Each year, worldwide, approximately 15 million infants are
born preterm less than 37 weeks’ gestation, including
446,850 preterm infants in the United States alone.1–3
Preterm birth (PTB) is the second leading cause of death
worldwide among children under the age of 5, and is the
leading cause of newborn death in the United States.1,2
Surviving neonates have significant risk of both major
and minor medical problems (with the potential to affect
all major organ systems as well as cognitive development).
These morbidities emerge in the immediate newborn peri-
od and may persist into childhood and adulthood.4–7 The
combination of prolonged hospitalization after birth,
increased need for early intervention services, and care
for related medical conditions result in staggering health-
care costs related to prematurity.8–12
Spontaneous PTB is multifactorial and thought to be a
“final common pathway,” as it is associated with a variety of
medical and obstetrical conditions. It is traditionally classi-
fied as either spontaneous (e.g., attributed to preterm pre-
mature rupture of membranes [PPROM] or idiopathic
preterm contractions) or indicated (e.g., attributed tomedical
and/or fetal causes necessitating delivery, such as pre-
eclampsia or fetal growth restriction). Increasing evidence
suggests that there may be substantial phenotypic overlap
between spontaneous and indicated PTB, as women with a
history of a prior spontaneous PTB have an elevated risk for
indicated PTB in a subsequent pregnancy and vice versa.13 It is
possible that PTB, regardless of eventual phenotype, all start
from a single common aberration, and then different envi-
ronmental and genetic influences lead to divergent
clinical phenotypes, but this is a largely untested hypothesis.
However, some researchers have recently found evidence of
placental insufficiency even in cases of idiopathic PTB, lend-
ing credence to this theory of a single underlying etiology for








Abstract Preterm birth (PTB) is a large public health problem in the United States and worldwide.
There is a clear genetic component to the pathogenesis of PTB, as evidenced by twin
studies, heritability studies, and investigations from large population databases.
Although numerous single nucleotide polymorphisms have been associated with
PTB, results have been inconsistent and overall disappointing. With recent advances
in genetic technology, investigations are moving beyond simple, more traditional
candidate gene studies, and have expanded to encompass more exploratory analyses
using high-throughput genetic techniques. Care should be taken to consider the
potential impact of fetal genotype, the environment, and gene–drug interactions
(pharmacogenomics) in addition to maternal genotype. Future research should capital-
ize on evolving analytic techniques, including pathway analyses and correlation of
genetic and functional data to optimize discovery, increase knowledge regarding
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suggest that whether the PTB phenotypically is spontaneous
or indicated is determined very early in pregnancy perhaps
even before or around the time of implantation and
placentation.14,15
Thus, although many factors that lead to PTB have been
described, overall, instigating causes are poorly understood
because the majority of risk factors are neither sufficient nor
necessary to result in PTB. Because PTB is multifactorial, both
exogenous and endogenous risk factors (and the interaction
of these risk factors) contribute to the underlying pathophys-
iology. Maternal and fetal genotypes are two risk factors that
have both been consistently implicated in the pathogenesis of
PTB across multiple studies, populations, and prematurity
phenotypes. Unfortunately, results of individual genetic
studies have been inconsistent and difficult to replicate.
This review focuses on an exploration of the evidence of
the heritability of PTB and the various approaches that
individual researchers have taken to investigate the genetic
contributions to PTB with a discussion of representative
associated results. Finally, we discuss opportunities for future
research direction.
Evidence of Preterm Birth Heritability
Multiple studies suggest genetic predisposition to PTB. One of
the strongest,most consistent risk factors for PTB is a personal
history of PTB. The odds of recurrent PTB (spontaneous or
indicated) vary but range from 1.6 to 10.6; higher odds are
seen for womenwith multiple prior PTB and a history of very
early prior PTB.13,16,17 In one study of consecutive pregnan-
cies, among women with a recurrent PTB, 49% delivered
within 1 week of the gestational age of their first delivery,
and 70% had a recurrent PTBwithin 2weeks of the gestational
age of their first delivery, suggesting that delivery gestational
age may be “genetically programmed” for some women.16
Other studies of consecutive pregnancies have also confirmed
that the greatest risk of recurrent PTB tends to occur around
the same gestational age that the PTB occurred in the first
pregnancy. This observation is true regardless of the prema-
turity subtype (indicated PTB vs. spontaneous PTB).13
The rate of PTB varies by race and ethnicity and is highest
among women of African descent.18–20 This ethnic disparity
persists after controlling for social and demographic
confounders.21 In a study of mixed race couples, there was
a graduated risk of PTB < 35 weeks’ gestation; compared
with a referent group of white mothers–white fathers, the
risk increased steadily with increasing contribution of black
genes, from a slightly increased risk among white mothers–
black fathers (adjusted odds ratio [aOR], 1.28; 95% confidence
interval [CI], 1.13–1.46) to amoderately increased risk among
black mothers–white fathers (aOR, 2.10; 95% CI, 1.68–2.62) to
the highest risk among black mothers–black fathers
(aOR, 2.28; 95% CI, 2.18–2.39).22 Similar results were found
in a different cohort, where the racial contribution of father
was again noted to be important, and again, black fathers did
not increase the risk of PTB as much as black mothers did
among interracial couples.23 These data provided further
credence to the notion that risk-predisposing alleles may be
more prevalent in the black population, but also emphasized
the importance of the contribution of both maternal and
paternal genes. In addition, blacks have been found to have
higher risks of recurrent PTB, and their recurrences tend to
occur at earlier gestational ages (mean of 31 vs. 33 weeks’
gestation) compared with whites. Another study examining
clinical phenotypes of PTB found blacks were more likely to
have maternal stress and cervical insufficiency phenotypes,
whereas white women had higher rates of decidual hemor-
rhage and placental dysfunction.24 Other studies have found
significant differences in biomarker profiles between blacks
and whites; with generally higher proinflammatory changes
in blacks.25–27 Taken together, this body of literature suggests
fundamental pathologic differences in PTB between blacks
and whites, of which there is likely a genetic component.28
Family studies have also suggested a genetic predisposi-
tion to PTB. In 1998, Winkvist et al studied a large Swedish
medical birth registry, and found an increased risk for PTB
among women whose sisters had a prior PTB (aOR, 1.94; 95%
CI, 1.26–2.99).29 Twin studies provide another means to
estimate heritability of a condition. Indeed, using data from
large cohorts of monozygotic and dizygotic twin pairs, inves-
tigators have estimated that the concordance of birth out-
comes among twin sibling pairs for the first-born offspring is
19 to 34%, a rate that is greater than expected by chance or
environment alone.30–32
Intergenerational studies across multiple different popula-
tions haveprovided further evidence for a genetic predisposition
to PTB. In 1997, Porter et al used theUtahPopulationDatabase to
study birth outcomes across generations. Women who them-
selves were born preterm were matched on several character-
istics towomenbornat term, and thedeliverygestational ages of
their offspring were compared. Preterm mothers had signifi-
cantly higher risks for PTB than termmothers (OR, 1.18; 95% CI,
1.02–1.37), and there was an inverse relationship with the
maternal gestational age at birth (those mothers who them-
selves were delivered < 30 weeks had higher odds for PTB; OR,
2.38; 95% CI, 1.37–4.16).33 Similar results were found in a
Swedish cohort, which confirmed that being preterm was
associated with an increased risk of then delivering a preterm
child later in life (aOR, 1.39; 95% CI, 1.29–1.50).34 Another large
population study fromUtah separated the effects of the fetal and
maternal genomes on gestational age, and estimated that the
heritability of gestational age ranges from 13.3 to 24.5%.35
Identification of “Prematurity Gene(s)”—
The Candidate Gene Approach
Candidate gene studies focus on specific, biologically relevant
regions of the genome that are suspected to be involved in the
pathogenesis of a condition. They are generally the most
affordable type of genetic study (although the cost per
polymorphism can be relatively expensive depending on
the technology used). Candidate gene studies can include
one gene or a handful of genes or encompass a larger gene
panel (either custom or predefined by amanufacturer).36 This
approach is limited by reliance on a priori knowledge about
known or theoretical biology of disease. Because allele
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frequencies vary by race/ethnicity, critics also argue that
population stratification contributes to inconsistent results
between populations.37 Although population stratification is
a concern in all genetic studies, in the case of candidate gene
studies, it is particularly highlighted due to the smaller
number of genetic variants that are often examined.
The majority of published studies of the genetics of PTB
have been candidate gene studies.Many of thesehave focused
on polymorphisms in genes involved with inflammation or
the response to infection. Previous work has provided
evidence that inflammation is involved in preterm labor
and delivery as evidenced through increased levels of inflam-
matory markers in women with spontaneous PTB.38,39
Although inflammation is often present in the decidual
tissues of women delivering preterm, the association is not
simple or straightforward.40 An increase in inflammatory
cytokines is not seen in all PTB, and many women with PTB
have chronic inflammation (e.g., due to obesity or autoim-
mune disease) but no evidence of infection.41–43 Likewise,
some have infection but no inflammation.43 Thus, other
factors (perhaps genetics or other environmental influences
or exposures) impact an individual’s response to noxious
infectious or proinflammatory stimuli. Multiple studies
have documented associations between cytokine polymor-
phisms and PTB, most consistently interleukin (IL)-1, IL-4,
matrix metalloproteinases, natural killer cells, and toll-like
receptors.44–47 Because polymorphisms in these genes are
not associated with PTB in all women from all populations,
this suggests a role for gene–environment interactions, but
the mechanisms remain poorly understood.48
Recently, several groups of investigators have performed
systematic reviews and/or meta-analyses of genetic associa-
tion studies, providing increased power and evidence beyond
what the individual studies have been able to provide. The
incorporation of gene–environment interaction information
into candidate gene studies (either at the onset or post hoc) is
important and can add a key additional element contributing
depth to the analysis.
One example is the genetic reviewpublished by Crider et al
in 2005. In this review of 18 studies, the authors summarized
the associations between genetic polymorphisms in inflam-
matory cytokines and other immune modulators and PTB.45
The authors noted that the majority of sample sizes were
small, frequently were convenience samples of high-risk
referral hospital populations, and study outcomes and defi-
nitions varied widely. The most frequently studied and most
consistent positive association was seen with the tumor
necrosis factor α (TNF-α) gene.45 TNF-α is a proinflammatory
cytokine which influences cervical remodeling and fetal
membrane integrity; carriage of the minor allele at position
-308A is associated with an increased risk of PTB and cho-
rioamnionitis.49 In one functional study, women with the
minor allele at -308A produce significantly higher levels of
TNF-α in response to lipopolysaccharide stimuli compared
with women with the major allele, which may be a possible
explanation for this association.50 Macones et al found a
possible gene–environment interaction involving TNF-α;
carriage of the -308A allele alone was associated with an
increased risk of PTB (OR, 2.7; 95% CI, 1.7–2.5), but among
women who also had bacterial vaginosis, the risk was even
higher (OR, 6.1; 95% CI, 1.9–21.0).51
Another example of a modern application of candidate
gene data in the study of PTB is exemplified by a meta-
analysis published in 2013 by Wu et al. These authors
performed a systematic review and meta-analysis evaluating
the association between IL-6 and PTB. This association had
previously been inconsistently reported.52 Ten studies eval-
uating the maternal and/or fetal genotype for rs1800795
(a single nucleotide polymorphism [SNP] in the IL-6 promoter
region, also commonly referred to as the “IL-6 -174” poly-
morphism) were analyzed, and encompassed 1,165 PTB and
3,830 term controls. Among women of European ancestry,
the rs1800795 CC genotype was protective against PTB
(OR, 0.68; 95% CI, 0.51–0.91), but there was no association
between the rs1800795 genotype and PTB among non-
European women (OR, 1.01; 95% CI, 0.59–1.75). When fetal
genotypes were analyzed, no significant association between
rs1800795 genotype and PTB (OR, 0.98; 95% CI, 0.72–1.33)
was found. These findings emphasize the important role of
population stratification in genetic association studies.52
Candidate gene studies have also examined SNPs in other
proposed PTB etiologic pathways. For example, investigators
have studied genes that may be associated with uterine
quiescence, including SNPs in the A kinase anchor protein
(PRKA) gene, known to impact muscle contraction and
myometrial quiescence, and found an association between
two polymorphisms (rs119672 and rs169412) and term
delivery.53 Other studies have also investigated polymor-
phisms in the human relaxin gene (RLN); SNPS in this gene
have been associated with PPROM, and others have theorized
that it mayalso impact uterine quiescence.54 In a small nested
case–control study performed by the Danish National Birth
Registry, maternal RLN2 genotype was associated with PTB
and PPROM.55
Numerous other genes have been associated with PTB
through candidate-gene investigations; the aforementioned
genes are merely examples. A complete listing of all genes
would not be possible and is outside of the scope of this
article. A comprehensive list (as of 2012), including 617 genes
identified by curation of more than 900 articles, microarray
and proteomic databases, and pathways, is available online
through the Database for Preterm Birth (dbPTB) project,
hosted by Brown University (database URL: http://ptbdb.cs.
brown.edu/dbPTBv1.php) (►Table 1).56
Larger Scale Genome-Wide Investigations,
Linkage Analyses, and Pathway Analyses
High-throughput genotyping approaches include larger SNP
panels, genome wide association studies (GWAS, covering mil-
lions of SNPs), microarray, andwhole exome andwhole genome
sequencing. Theadvantageof these approaches is that there is no
(or significantly less) bias in the selectionof genes. This allows for
increased “discovery” science and exploration of previously
unsuspected avenues of genetic association, and exploits the
power of gene ontology by grouping genes with similar basic
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functions. Thismethodology is notwithoutdrawbacks, however.
Most high-throughput genotyping platforms are expensive, and
resultant data analyses are challenging due to concerns regard-
ing multiple comparisons and high thresholds for statistical
significance to reduce the probability of false positives. Further,
there is no clear “roadmap” regarding the most appropriate
methodology for this type of genetic analysis, and the analytic
methods are complex due to themassive volumeof data, and are
thus continuously evolving. However, an increasing number of
tools have been designed, and enable scientists to sort through
and analyze these complex genetic data. Many are available
online, at no charge (►Table 1). These include pathway analysis
tools, which provide themeans to take a large gene list and pare
it down to a smaller, more meaningful and focused prioritized
list. Described below are examples of high-throughput genetic
analyses of PTB, demonstrating how these types of analyses
provide additional power in the study of prematurity.
Velez et al evaluated 1,536 SNPs in 130 candidate genes from
hypothesized PTB pathways, and found an association between
maternal genotype and prematurity among several comple-
ment-coagulation pathway genes among Caucasians (including
factor V, factor VII, tissue plasminogen activator).57 The authors
also found an association between fetal genotype and inflam-
matory pathways (IL-10 receptor antagonist), leading them to
conclude that there are potentially different maternal and fetal
genetic risks for PTB among Caucasians.57 This is in contrast to
the results of companion studies performed by the same group
among a cohort of African Americans, which demonstrated a
strong association between genes involved in infection and
inflammation (namely, IL-10 and fetal IL-2 receptor β), and
PTB. In the African American analysis, there were more pro-
nounced fetal than maternal effects.58
Zhang et al reported results from a large, multicenter GWAS
study of early PTB, which included 959 case mothers and 979
case neonates (all delivered < 34 weeks’ gestation) compared
with 960 control mothers and 985 control neonates (all deliv-
ered  39 weeks’ gestation).59 Both maternal and fetal samples
were genotyped with a large established SNP Array (Affymetrix
6.0; Affymetrix, Santa Clara, CA). Although20maternal SNPs had
p-values ranging from 1.0  106 to 4.105, no maternal SNPs
reached formal genome-wide significance. Two neonatal SNPs,
rs17527054 (located on chromosome 6p22 in the area of the
major histocompatibility complex) and rs3777722 (located on
chromosome 6q27 in the RNASET2 gene) reachedgenome-wide
significance, but the findings were unable to be replicated after
adjusting for multiple comparisons in a validation cohort. The
authorsnoted thatmanyof their topSNPs, althoughnot reaching
formal genome wide significance, were located in genes or
genomic regions involved in pathways previously implicated
in PTB (e.g., inflammation and immunity).59
In another reviewwhich included a pathway analysis, Capece
et al identified 15 genetic association studies conducted in 3,600
women encompassing 2,175 SNPs in 274 genes. The authors
used Ingenuity Pathway Analysis (IPA; QIAGEN Redwood City,
www.qiagen.com/ingenuity) todetermine if genetic associations
differed between idiopathic PTB and PPROM. They concluded
Table 1 Examples of publically available analytic tools for genetic research of prematurity
Broad category Name Brief description
Database of genes
associated with PTB
Database for Preterm Birth (dbPTB)64 Web-based aggregation tool to organize genes, genetic




PLINK65 Analysis of genotype and phenotype data; designed to
perform a range of basic, large scale analyses in a
computationally efficient manner
Variant Annotation, Analysis, and
Search Tool (VAAST)66,67
Probabilistic search tool for identifying damaged genes
and their disease causing variants in personal genome
sequences
Pathway analysis Database for Annotation,
Visualization, and Integrated
Discovery (DAVID) v. 6.768,69
Comprehensive set of functional annotation tools for
investigators to understand biological meaning behind
large lists of genes
Kyoto Encyclopedia of Genes and
Genomes (KEGG)
Database resource for understanding high-level




Classifies proteins and their genes to facilitate
high-throughput analysis
Phenotype driven variant ontological
re-ranking tool (Phevor)70
Integrates phenotype, gene function, and disease
information with personal genomic data for improved
power to identify disease-causing alleles. Combines
knowledge from biomedical ontologies with outputs of
variant prioritization tools
Evolutionary biology GEneSTATION 1.071 Resource of diverse evolutionary and functional genomic
data for studying the evolution of pregnancy-associated
tissues and phenotypes
Abbreviation: PTB, preterm birth.
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that idiopathic spontaneous PTB is associatedwith autoimmune
and hormonal regulation pathways; in contrast, hematologic/
coagulation function disorders, collagen metabolism, matrix
degradation, and local inflammation pathways were implicated
in PPROM.60
Identification of “Prematurity Gene(s)”—The
Future
There is a clear need to optimize genetic studies of prematurity.
Utilization of large, multiplex genetic platforms focused on
individuals with a specific PTB phenotype or individuals from
asingle familyor familieswithPTBmay increase the likelihoodof
detecting genetic variants associated with this disease. Further-
more, as genetic analysis technology continues to improve,
utilization of next-generation sequencing data are increasingly
more accessible andwidespread, andwill help researchersmove
away from preconceived notions regarding the genetic variants
involved in the pathogenesis of prematurity.
Although this review focuses on genomics, the importance
of epigenetics and proteomics in the study of PTB should not
be overlooked, as these areas also provide very valuable
information into the pathophysiology of this complex
disorder.61,62 It is an exciting time to utilize the increasing
knowledge of biologic pathways, harness the power of
analytic algorithms, as well as consider gene–environment
and gene–drug (pharmacogenomics) effects when designing
studies, analyzing data, and synthesizing results.63
Conclusion
PTB is a large public health problem in the United States and
worldwide. Although there is a clear genetic component to
the pathogenesis of PTB, maternal and fetal genotypes are
neither necessary nor sufficient for the development of this
complex syndrome. Care should be taken to consider not only
maternal genetic effects but also the potential impact of fetal
genotype, the environment, and gene–drug interactions
(pharmacogenomics). Future research should capitalize on
evolving analytic techniques, including pathway analyses and
correlation of genetic and functional data to optimize discov-
ery, increase knowledge regarding prematurity pathogenesis,
and begin to develop novel therapeutic strategies.
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